FAQ
Login
GNU social JPは日本のGNU socialサーバーです。
Usage
/
ToS
/
admin
/
test
/
Pleroma FE
Public
Public
Network
Groups
Featured
Popular
People
Embed Notice
HTML Code
<blockquote style="position: relative; padding-left: 55px;"><section><a href="https://todon.eu/users/jalcine/statuses/112651411073451521">✌🏿✍🏿 (jalcine@todon.eu)'s status on Friday, 21-Jun-2024 08:02:25 JST</a><a href="https://todon.eu/@jalcine" title="jalcine@todon.eu"><img src="https://gnusocial.jp/avatar/7870-48-20241025041136.webp" width="48" height="48" alt="✌🏿✍🏿" style="position: absolute; left: 0; top: 0;">✌🏿✍🏿</a></section><article><p>Good news. <a href="https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html" rel="nofollow noreferrer">https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html</a></p></article><footer><a rel="bookmark" href="https://gnusocial.jp/conversation/3270935#notice-6449951">In conversation</a><time datetime="2024-06-21T08:02:25+09:00" title="Friday, 21-Jun-2024 08:02:25 JST">about 5 months ago</time> <span>from <span><a href="https://todon.eu/@jalcine/112651411073451521" rel="external" title="Sent from todon.eu via ActivityPub">todon.eu</a></span></span><a href="https://todon.eu/@jalcine/112651411073451521">permalink</a><h4>Attachments</h4><ol><li><article><header><div>Domain not in remote thumbnail source whitelist: image.cnbcfm.com</div><h5><a href="https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html">Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial</a></h5><div> from <span>https://www.facebook.com/CNBC</span></div></header><div>Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday.</div><footer></footer></article></li></ol></footer></blockquote>
Corresponding Notice
Embed this notice
✌🏿✍🏿 (jalcine@todon.eu)'s status on Friday, 21-Jun-2024 08:02:25 JST
✌🏿✍🏿
Good news.
https://www.cnbc.com/2024/06/20/gilead-prep-lenacapavir-succeeds-in-phase-3-trial.html